Daily as of 3 Nov 16:00 ET
- Price
- between the two $8.24 vs 50 $8.10 / 200 $20.60
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 3 Aug 2026 · projected 30 bars out
CAPR | Capricor TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$8.24
+$1.00 (+13.81%)
Capricor Therapeutics (CAPR) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $6.38 vs 50 $20.76 / 200 $10.78
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 9 Sep 2024 · projected 1 bar out · tested 2 bars
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $8.24 vs 50 $7.17 / 200 $12.20
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 11 Jun 2026 · projected 20 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 3 Aug 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 11 Jun 2026 | 💀Death | 4-hour | 20 bars out | Not tested |
| 12 Dec 2025 | 🟨Golden moderate | daily | 6 bars out | Not tested |
| 4 Dec 2025 | 🟨Golden | 4-hour | 2 bars out | Not tested |
| 30 Apr 2025 | 💀Death moderate | daily | 28 bars out | 3 bar cross test |
About CAPR
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$23.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall